‹ All Posts
VIJAY KUMAR GUPTA

11th Dec · SEBI-Registered Analyst

JUBLPHARMA
Jubilant Pharmova Ltd

JUBLPHARMA
🔬 Company Snapshot Jubilant Pharmova Ltd is a major integrated pharmaceutical and life-sciences company based in Noida, Uttar Pradesh, India. It operates globally, serving markets in North America, Europe, Asia, and other regions through a wide range of health-care and research businesses. 🧠 What the Company Does Jubilant Pharmova’s operations span multiple segments in the pharmaceutical value chain: 1️⃣ Pharmaceuticals Produces and supplies therapeutic products including radiopharmaceuticals and allergy-therapy products. Radiopharmaceuticals are used in diagnosis and treatment of diseases such as cancer and thyroid disorders. Allergy immunotherapy products help manage allergic conditions. 2️⃣ Contract Development & Manufacturing (CDMO) Offers contract manufacturing of sterile injectables and non-oral pharmaceutical products. Provides manufacturing of active pharmaceutical ingredients (APIs) and formulation products. Serves global pharma companies that outsource development and production. 3️⃣ Generics Manufactures and markets generic pharmaceutical products across various therapeutic categories. 4️⃣ Contract Research & Development (CRDMO) Through research centers provides drug discovery services, formulation development and related research for global clients. 5️⃣ Proprietary Novel Drugs Works on new drug development, particularly in areas such as oncology and autoimmune diseases. Overall, the company is vertically integrated — covering research, development, manufacture, and distribution of a broad set of pharmaceutical and life-science products. 🌍 Global Presence Jubilant Pharmova operates: Manufacturing facilities in India, the United States, and Canada. A network of radiopharmacies in the United States that support distribution of radiopharmaceutical products. Research and development centers in India and North America.

#Budget2025#Today’sTradingSetup#WatchOutFor#StockInNews#FundamentalViews
Screenshot 2025-12-11 140454.png
1,197 likes·74 comments